<?xml version='1.0' encoding='utf-8'?>
<document id="31516092"><sentence text="A life-threatening drug-drug interaction between capecitabine and brivudine in a patient with metastatic breast cancer."><entity charOffset="49-61" id="DDI-PubMed.31516092.s1.e0" text="capecitabine" /><entity charOffset="66-75" id="DDI-PubMed.31516092.s1.e1" text="brivudine" /><pair ddi="false" e1="DDI-PubMed.31516092.s1.e0" e2="DDI-PubMed.31516092.s1.e0" /><pair ddi="false" e1="DDI-PubMed.31516092.s1.e0" e2="DDI-PubMed.31516092.s1.e1" /></sentence><sentence text="In the current report we present the case of a patient experiencing a life-threatening drug-drug interaction involving the concurrent administration of capecitabine and brivudine"><entity charOffset="152-164" id="DDI-PubMed.31516092.s2.e0" text="capecitabine" /><entity charOffset="169-178" id="DDI-PubMed.31516092.s2.e1" text="brivudine" /><pair ddi="false" e1="DDI-PubMed.31516092.s2.e0" e2="DDI-PubMed.31516092.s2.e0" /><pair ddi="false" e1="DDI-PubMed.31516092.s2.e0" e2="DDI-PubMed.31516092.s2.e1" /></sentence><sentence text=" A 65- year-old female with metastatic breast cancer was commenced on brivudine for Herpes Zoster, while on capecitabine treatment, by a physician unfamiliar with the potential repercussions of this drug-drug interaction"><entity charOffset="70-79" id="DDI-PubMed.31516092.s3.e0" text="brivudine" /><entity charOffset="108-120" id="DDI-PubMed.31516092.s3.e1" text="capecitabine" /><pair ddi="false" e1="DDI-PubMed.31516092.s3.e0" e2="DDI-PubMed.31516092.s3.e0" /><pair ddi="false" e1="DDI-PubMed.31516092.s3.e0" e2="DDI-PubMed.31516092.s3.e1" /></sentence><sentence text=" As a result, she developed skin rash, severe oral mucositis, and severe and prolonged pancytopenia" /><sentence text=" These side effects were attributed to a serious interaction of capecitabine with brivudine, resulting in inhibition of dihydropyrimidine dehydrogenase"><entity charOffset="64-76" id="DDI-PubMed.31516092.s5.e0" text="capecitabine" /><entity charOffset="82-91" id="DDI-PubMed.31516092.s5.e1" text="brivudine" /><entity charOffset="120-137" id="DDI-PubMed.31516092.s5.e2" text="dihydropyrimidine" /><pair ddi="false" e1="DDI-PubMed.31516092.s5.e0" e2="DDI-PubMed.31516092.s5.e0" /><pair ddi="false" e1="DDI-PubMed.31516092.s5.e0" e2="DDI-PubMed.31516092.s5.e1" /><pair ddi="false" e1="DDI-PubMed.31516092.s5.e0" e2="DDI-PubMed.31516092.s5.e2" /><pair ddi="false" e1="DDI-PubMed.31516092.s5.e1" e2="DDI-PubMed.31516092.s5.e1" /><pair ddi="false" e1="DDI-PubMed.31516092.s5.e1" e2="DDI-PubMed.31516092.s5.e2" /></sentence><sentence text=" The patient was admitted for supportive care including intravenous hydration, parenteral nutrition, mouth care solutions, fluconazole, antimicrobial therapy, filgrastim, red blood cell and platelet transfusions"><entity charOffset="123-134" id="DDI-PubMed.31516092.s6.e0" text="fluconazole" /></sentence><sentence text=" She successfully recovered and was discharged on the 26th day after her admission" /><sentence text=" Drug-drug interactions can be serious, even life-threatening; thus the physicians should be cautious when prescribing new drugs" /><sentence text="" /></document>